Most glaucoma patients don't ask about medication costs

December 2, 2017, Wolters Kluwer Health

Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

High are an important barrier to regular use of medications, and have been linked to more severe disease and faster progression. Doctor-patient communications might be one way to learn about how cost issues affect patients' adherence to using medications as prescribed.

Medication costs are discussed in less than one-third of glaucoma visits, according to the new study by Catherine Slota, PhD, of RTI International, Research Triangle Park, N.C., and colleagues. They encourage vision care professionals to talk about with their glaucoma patients—especially those without prescription drug coverage, who may be at increased risk of low adherence.

Vision Professionals Should Ask About Costs of Glaucoma Medications

Glaucoma is a chronic, incurable eye disease affecting more than 2 million Americans—a number that is expected to rise as the population ages. "Some of the most commonly utilized treatments require lifelong use, requiring high patient adherence to ensure effectiveness," Dr. Slota and coauthors write.

They analyzed video recordings of 275 office visits between glaucoma patients and ophthalmologists, drawn from a larger study of glaucoma communication. The analysis focused on the frequency and nature of communication regarding the cost of glaucoma medications. Most patients had mild glaucoma and were taking a single medication. Nearly all had health insurance, usually including prescription drug coverage.

Overall, the patient and doctor discussed medication costs in about 31 percent of visits. In about five percent of visits, the patient indicated that the cost of glaucoma medications was a problem—mainly patients who did not have medical insurance.

Some patients said that cost issues affected the way they used their glaucoma medications. As one patient said, "Sometime maybe I forget purposely because they're so darn expensive."

In about 18 percent of visits, the physician suggested possible solutions to cost problems, such as switching to a generic or alternative medication. Other suggestions included ordering a three-month supply, working with the pharmacist, or using prescription drug discount programs.

The patient and doctor talked about health insurance or in about 15 percent of visits. These conversations were more likely when the patient was starting glaucoma medications for the first time.

The researchers note some limitations of their study—notably including the fact that nearly all of the patients had health and prescription drug insurance. They suggest further studies of cost issues in uninsured patients and other groups at high risk of nonadherence to glaucoma medications.

The results add to previous evidence that few discuss the costs of glaucoma medications with their vision care professionals. Dr. Slota and coauthors conclude, "Physicians should consider bringing up medication cost during glaucoma office visits to prompt a discussion of potential cost-related barriers to medication use."

Explore further: Generic eye drops for seniors could save millions of dollars a year

More information: Catherine Slota et al. Patient-Physician Communication on Medication Cost during Glaucoma Visits, Optometry and Vision Science (2017). DOI: 10.1097/OPX.0000000000001139

Related Stories

Generic eye drops for seniors could save millions of dollars a year

July 28, 2017
(HealthDay)—Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests.

Scientists engineer drug delivery device that treats glaucoma directly inside the eye

November 23, 2017
Glaucoma, which affects over 60 million people worldwide, can seem easy to treat: medicated eye drops can be used to ease the buildup of fluid in the eye that underlies the condition. If glaucoma is caught early, eye drops ...

XEN-45 implant effective in uncontrolled uveitic glaucoma

October 29, 2017
(HealthDay)—For medically uncontrolled uveitic glaucoma, the XEN-45 implant is effective, reducing the need for further surgery, according to a study published online Oct. 20 in Clinical & Experimental Ophthalmology.

Six things PCPs need to know about glaucoma

December 23, 2016
(HealthDay)—Primary care physicians are in a position to help with glaucoma diagnosis and management, according to an article published in the Ophthalmology Times.

Expenditures for glaucoma medications appear to have increased

June 13, 2011
In recent years, spending for glaucoma medications has increased, especially for women, persons who have only public health insurance and those with less than a high school education, according to a report published Online ...

With generic drugs, eye patients are more likely to take medicine as directed

February 11, 2015
When patients with glaucoma switched from a brand name drug to its generic counterpart, they were more likely to take their medication as directed compared to those who remained on the brand name drug, according to a study ...

Recommended for you

Older adults with small social networks less likely to get cataract surgery

March 9, 2018
Close family relationships and a strong social network may help older adults see the world better—literally.

A retinal implant that is more effective against blindness

March 9, 2018
EPFL researchers have developed a new type of retinal implant for people who have become blind due to the loss of photoreceptor cells in their retinas. The implant partially restores their visual field and can significantly ...

New imaging technique could improve the diagnosis, treatment of glaucoma

March 7, 2018
The National Eye Institute, part of the National Institutes of Health, projects the number of Americans affected by glaucoma will more than double between 2010 and 2050, from 2.7 million to 6.3 million.

New gene therapy corrects a form of inherited macular degeneration in canine model

March 5, 2018
Researchers from the University of Pennsylvania have developed a gene therapy that successfully treats a form of macular degeneration in a canine model. The work sets the stage for translating the findings into a human therapy ...

New insights into how the retina processes orientation

February 26, 2018
In a study published in Nature Communications, Northwestern Medicine scientists detail the discovery of two types of cells in the retina that determine horizontal or vertical orientation, and demonstrated for the first time ...

Glaucoma study finds brain fights to preserve vision

February 23, 2018
A team of researchers, led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.